Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL was delisted on the 21st of February, 2024.
0 hedge funds and large institutions have $0 invested in Gracell Biotechnologies Inc. American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 63 closing their positions.
100% less funds holding
Funds holding: 63 → 0 (-63)
100% less funds holding in top 10
Funds holding in top 10: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $553M → $0 (-$553M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 63
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
-$96.3M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$95.8M |
| 3 |
O
OrbiMed
New York
|
-$93.5M |
| 4 |
SCM
Sio Capital Management
New York
|
-$50.2M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$45.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
JP Morgan Chase
New York
| – | -$141K | -13,999 | Closed |
|
|
VF
52
Virtu Financial
New York
| – | -$109K | -10,896 | Closed |
|
53
Barclays
London,
United Kingdom
| – | -$106K | -10,517 | Closed |
|
|
FIA
54
FNY Investment Advisers
New York
| – | -$100K | -10,000 | Closed |
|
|
CUAMC
55
China Universal Asset Management Company
Shanghai,
China
| – | -$84.4K | -8,405 | Closed |
|
|
EPM
56
Equitec Proprietary Markets
Chicago,
Illinois
| – | -$74.3K | -7,400 | Closed |
|
57
Wells Fargo
San Francisco,
California
| – | -$72.2K | -7,194 | Closed |
|
|
TRCT
58
Tower Research Capital (TRC)
New York
| – | -$54.9K | -5,465 | Closed |
|
59
Simplex Trading
Chicago,
Illinois
| – | -$16K | -1,622 | Closed |
|
60
Citigroup
New York
| – | -$13.2K | -1,316 | Closed |
|
|
EBA
61
Eagle Bay Advisors
New York
| – | -$2.11K | -210 | Closed |
|
62
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$1.51K | -150 | Closed |
|
63
Daiwa Securities Group
Tokyo,
Japan
| – | -$1K | -146 | Closed |
|
GRCL Hedge Fund Activity: Q1 2024 in Review
0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q1 2024, worth a combined $0 — down 100% from $553M a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of GRCL and 0 opened new positions — a net loss of 63 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Temasek Holdings, exiting entirely with an estimated $96.3M sold.
- 0 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q1 2024, down from 63 in Q4 2023.
- Funds reported $0 of Gracell Biotechnologies Inc. American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q1 2024 and 63 closed out, a net change of -63 holders.
- The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q1 2024 was Temasek Holdings, an estimated $96.3M sold.
Based on aggregated 13F filings for Q1 2024.